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ABSTRACT 29 
During infection of their human definitive host, schistosomes transform rapidly from free-swimming 30 
infective cercariae in freshwater to endoparasitic schistosomules. The ‘somules’ next migrate 31 
within the skin to access the vasculature and are surrounded by host molecules that might activate 32 
intracellular pathways that influence somule survival, development and/or behaviour. However, 33 
such ‘transactivation’ by host factors in schistosomes is not well defined. In the present study, we 34 
have characterized and functionally localized the dynamics of protein kinase C (PKC) and 35 
extracellular signal-regulated kinase (ERK) activation during early somule development in vitro and 36 
demonstrate activation of these protein kinases by human epidermal growth factor, insulin, and 37 
insulin-like growth factor I, particularly at the parasite surface. Further, we provide evidence that 38 
support the existence of specialized signalling domains called lipid rafts in schistosomes and 39 
propose that correct signalling to ERK requires proper raft organization. Finally, we show that 40 
modulation of PKC and ERK activities in somules affects motility and reduces somule survival. 41 
Thus, PKC and ERK are important mediators of host-ligand regulated transactivation events in 42 
schistosomes, and represent potential targets for anti-schistosome therapy aimed at reducing 43 
parasite survival in the human host. 44 
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Introduction 58 
Schistosomes are formidable multicellular blood parasites. Human-infective species such as 59 
Schistosoma mansoni and S. haematobium penetrate the skin as cercariae in freshwater, 60 
transform into skin schistosomules (somules) and then migrate in the vasculature, and develop 61 
further into male and female immature worms. These worms pair, mature and migrate to the egg 62 
laying site; a female can produce hundreds of eggs each day many of which are released in the 63 
faeces or urine enabling parasite transmission via a snail intermediate host1. Eggs not expelled 64 
from the definitive host get trapped in tissues and elicit chronic immune responses causing 65 
granulomas that result in the neglected tropical disease (NTD) human schistosomiasis2. The 66 
importance of this NTD is considerable; approximately 230 million people are infected across 76 67 
developing countries and 0.8 billion are at risk of infection3.  68 
Upon skin invasion the schistosome must quickly adapt to survive in the new environment 69 
of the human host. To facilitate survival, immunomodulatory molecules are released by cercariae 70 
during invasion4 and each cercaria undergoes complex transformation into a biochemically distinct 71 
skin somule5 which develops a specialised syncytial tegument that remains into adulthood. This 72 
unique host-interactive layer has been the focus of much research, especially because it 73 
expresses potential drug and vaccine targets6–10. Even at this early stage of parasitism, the 74 
schistosome likely exploits host-signalling molecules to support its development and sustain 75 
homeostasis, and host-parasite communication could occur via the tegument. However, the extent 76 
to which human host molecules influence schistosome cellular mechanisms remain largely 77 
unknown.  78 
In eukaryotes, protein kinase C (PKC) and extracellular signal-regulated kinase/mitogen-79 
activated protein kinase (ERK/MAPK) regulate diverse processes such as growth, development 80 
and differentiation, the cell cycle, motility, apoptosis and survival11,12. These intracellular signalling 81 
proteins/pathways are activated by stimuli including ligands that bind to transmembrane G-protein 82 
coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs). In S. mansoni, four PKC-like 83 
proteins have been identified which share homology to human PKCs particularly within their 84 
functional domains: two conventional PKCβ, one novel PKCε, and one atypical PKCζ13–15, with 85 
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PKCε also been designated PKCη16. Putative upstream PKC regulators such as phospholipase C 86 
(PLC) also exist17. In respect of the ERK pathway, which comprises Ras as a monomeric GTP-ase 87 
switch protein, Raf as a MAPKKK, MAPK/ERK kinase (MEK) as a MAPKK, and ERK as a MAPK, 88 
in S. mansoni a Ras GTPase activator protein has been detected18, and Ras and ERK 89 
homologues characterized15,18,19.  90 
Signalling across cellular plasma membranes is considered to occur through dynamic 91 
membrane/lipid rafts, which are nanoscale microdomains present in the lipid bilayer that assemble 92 
cholesterol and sphingolipids and subsets of transmembrane or glycosylphosphatidylinisotol (GPI)-93 
anchored proteins20. These structures are presumed to also selectively concentrate intracellular 94 
signalling molecules providing platforms for where protein kinases, scaffolding molecules, and 95 
substrates are brought into close proximity enabling rapid signal transduction21. These rafts also 96 
play a part in membrane trafficking22,23. Raft formation is most likely controlled by proteins, 97 
including caveolins and flotillins24 that probably organize rafts into microdomains23. In 98 
schistosomes putative caveolae-like structures, possibly formed by caveolin-like molecules, have 99 
been described in the surface (tegumental) membrane, and membrane fractions characteristic of 100 
detergent-insoluble glycosphingolipid-enriched membrane domains (DIGs) or detergent-resistant 101 
membranes (DRMs) have been prepared25, indicating lipid raft presence in vivo23.  102 
Here we have characterized ERK and PKC signalling in somules of S. mansoni during early 103 
development in vitro and show that these pathways are transactivated by host epidermal growth 104 
factor (EGF), insulin, and insulin-like growth factor I (IGF-I). We provide evidence to further support 105 
the presence of lipid rafts at the schistosome surface and propose that signalling to kinases such 106 
as ERK occurs through these rafts. Finally we show that modulation of PKC and ERK activities 107 
affects somule motility, phenotype, and reduces somule survival. 108 
 109 
Results  110 
Characterization of PKC and ERK activation during early somule development. Anti-phospho 111 
antibodies, validated by us for detecting S. mansoni PKCs and ERKs when in an exclusively 112 
phosphorylated (activated) state13,15, were employed here to characterize and localize the 113 
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phosphorylation (activation) dynamics of PKCs and ERKs in mechanically transformed somules 114 
maintained in vitro for four days. Such somules are similar to skin-transformed somules and the 115 
transformation of the tegument occurs rapidly in vitro26,27. In immunohistochemistry, control 116 
somules probed only with secondary antibodies consistently displayed negligible fluorescence 117 
(Supplementary Figure 1). Using anti-phospho PKC (Ser660) and anti-phospho PKC (Thr410) 118 
antibodies that recognize activation motifs in S. mansoni PKCs that are conserved with human 119 
PKCs15, three phosphorylated (activated) PKCs were consistently detected in somules with 120 
apparent molecular weights of ~78, ~81, and ~116 kDa (Fig. 1a). Based on immunoreactivity 121 
profiles and conservation of amino acids within the key activation motifs these PKCs have been 122 
tentatively assigned Smp_128480 (conventional PKCβ-type), Smp_096310 (atypical PKCι-type), 123 
and Smp_176360 (conventional PKCβ-type), respectively as previously reported15. Each of these 124 
PKC genes are expressed in 3 h and 24 h somules (data available at GeneDB). A larger (~132 125 
kDa) PKC-like protein was also sometimes detected, albeit weakly (Fig. 1a). Digital analysis of 126 
western blot bands from four separate experiments revealed that activation of the ~78, ~116, and 127 
~132 kDa PKCs did not change significantly over four days when compared to 3 h somules; 128 
however, ~81 kDa PKC activation was consistently upregulated at 72 h and was sustained at 96 h 129 
when compared to 3 h somules (Fig. 1a) (~2.4 fold increase; p≤0.001). Localization of activated 130 
PKCs within intact somules during early development with anti-phospho PKC (Ser660) antibodies 131 
using confocal laser scanning microscopy revealed that activated PKC was differentially distributed 132 
over time, with activation at the tegument at 3 h and 16 h, which declined thereafter, with greater 133 
activation seen within the somule body at 96 h (Fig. 1b). Using anti-phospho PKC (Thr410) 134 
antibodies, activated PKC was seen at the tegument and various internal structures throughout 135 
development with considerable sub-tegumental activation seen at 96 h, together with activation at 136 
structures resembling the nerve cords and cephalic ganglia (Fig. 1b). Similar to three of the PKCs, 137 
the activities of the ~43 kDa and ~48 kDa ERK proteins detected using anti-phospho p44/42MAPK 138 
(Thr202/Tyr204) (ERK1/2) antibodies did not change significantly during early somule development 139 
in vitro (Fig. 1a). Confocal microscopy analysis of somules over 96 h revealed activated ERK was 140 
generally associated with the tegument region (Fig. 1b).   141 
 142 
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Induction of somule PKC and ERK signalling by human EGF, Insulin and, IGF-I. We next 143 
sought to investigate the effects of host molecules on PKC and ERK signalling in somules. Two-144 
day old somules were starved overnight in BME only and then treated with human EGF (15 ng/ml). 145 
EGF exposure resulted in a transient, significant induction of PKC (81 kDa) and ERK (43 kDa) 146 
activation, with maximal ~2-fold (p≤0.001) and ~1.6-fold (p≤0.001) increases seen at 15 and 30 147 
min, respectively (Fig. 2a); activation of the other PKC and ERK proteins remained unaffected (Fig. 148 
2a). Anti-phospho PKC (Thr410) and anti–phospho p44/42MAPK (Thr202/Tyr204) (ERK1/2) 149 
antibodies were therefore used to localize activated PKCs and ERKs in somules at these time 150 
points. EGF treatment caused a visible increase in PKC activation at the tegument and also at 151 
internal structures including a region resembling the oesophagus/oesophageal gland, particularly 152 
noticeable with deep scanning (Fig. 2b). There was also striking activation of ERK at the tegument, 153 
with a punctate distribution over the entire surface of the somule. Interestingly, enhanced activation 154 
of the 116 kDa PKC was evident when somules remained in Basch’s growth medium when 155 
compared to Eagles Basal Medium (BME) controls (Fig. 2a).  156 
 Addition of human insulin (1 μM) to starved somules significantly increased the activation of 157 
both the ~116 kDa PKC and ~43 kDa ERK at 30 min, by ~2-fold and ~3.2-fold, respectively, 158 
declining at 60 min (Fig. 3a). The activation status of the remaining PKCs and ERK were 159 
unaffected by insulin (Fig. 3a). Moreover, immunohistochemistry with anti-phospho PKC (Ser660) 160 
antibodies (that detect the 116 kDa PKC) revealed that after 30 min, activated PKC associated 161 
with acetabulum and distinct unidentified internal structures, whereas activated ERK also localized 162 
to the tegument with punctate distribution (Fig. 3b) similar to that with EGF (Fig. 2b).  163 
 In contrast to insulin, incubation of serum-starved somules with IGF-I (15 ng/ml) resulted in 164 
the activation of only the ~116 kDa PKC at 30 and 60 min (Fig. 3c). Deep scanning revealed 165 
activation present in the parenchyma and in regions resembling the oesophagus and, possibly the 166 
nephridiopore (Fig. 3c). 167 
  168 
Lipid raft markers and DRM behaviour support a role for lipid raft-mediated cell signalling in 169 
S. mansoni. Given that one day-old somules displayed activated PKC and ERK (Fig. 1), which 170 
localized to the tegument, further experiments investigating lipid rafts were conducted on ~24 h 171 
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somules that had not been cultured in serum. Similar to 3-day somules, preliminary experiments 172 
revealed that these somules also responded to EGF (data not shown). Lipid raft microdomains are 173 
characterized by their insoluble nature in non-ionic detergents as well as the presence of the 174 
constituent pentasaccharide gangliosideGM1. In an initial step to identify lipid rafts, somules were 175 
treated with EGF and stained with the Vybrant lipid raft labelling kit, which incorporates fluorescent 176 
cholera toxin subunit B (CT-B) that binds gangliosideGM1. GM1 clusters, indicative of lipid rafts, 177 
were observed at the somule surface following EGF treatment (Fig. 4a) with less staining seen 178 
without EGF. No fluorescence was observed in negative controls not incubated in CT-B (data not 179 
shown). Moreover, GM1 clusters were observed at the surface of adult S. mansoni (Fig. 4a).  180 
Next, to identify possible raft marker proteins in schistosomes, protein sequences for 181 
human flotillin-1, Gq and Ras were BLASTed against the S. mansoni genome, alignments 182 
generated, and antibodies selected to recognize the S. mansoni homologues based on target 183 
sequence. S. mansoni flotillin-1 (Smp_016200.3) is 62% identical to human flotillin-1 184 
(NP_005794.1; 48 kDa). Antibodies raised against amino acids 312-428 (that incorporate the 185 
conserved flotillin domain) of human flotillin-1 detected a band of ~48 kDa in somule and adult 186 
worm extracts, similar to the expected molecular weight of the S. mansoni protein (47 kDa). Two 187 
other flotillin splice variants, Smp_016200.1 and smp_016200.4 of 41 kDa and 43 kDa, 188 
respectively, are predicted in the S. mansoni genome and might be responsible for the two lower 189 
molecular weight bands detected (Fig 4b). S. mansoni G protein (Smp_005790; ~42 kDa) is 81% 190 
identical to human G protein subunit α-11 (Gq class; NP_002058) and anti-Gq/11α antibodies 191 
targeted to a region (QLNLKEYNLV) that is 100% conserved between the species recognized the 192 
putative S. mansoni 42 kDa protein (Fig. 4b). Finally, S. mansoni Ras (Smp_179910; 16 kDa), 193 
81% similar to human K-Ras (isoform a; NP_203524), was detected at ~20 kDa by an antibody 194 
targeted to the N-terminal region of human K-, H- and N-Ras (which is 100% similar between the 195 
species) (Fig. 4b). Immunohistochemistry localized flotillin, Gq, and Ras to the somule tegument 196 
and sub-tegument regions, cells within the parenchyma tissues and also internal structures that 197 
included the cephalic ganglia and a cluster of cells proximal to the acetabulum (Fig. 4b). High-198 
resolution imaging of the tegument region revealed punctate staining, particularly for flotillin and 199 
Gq (Fig. 4b). Detailed in situ analysis of activated ERK and PKC in these somules following EGF 200 
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treatment revealed overall similar distribution patterns, with activated ERK also detected at the 201 
oesophageal gland region (Fig. 4c). Because enrichment of a protein in a DRM preparation shows 202 
that it is raftophillic and that it is likely to associate with lipid rafts when they form23 we prepared 203 
DRMs28 from schistosomes using Triton X-100. Adult worms were used rather than somules to 204 
ensure that sufficient material was available for DRM preparation. Western blotting revealed that 205 
flotillin was enriched in the Triton-insoluble DRM fraction, indicating the presence of lipid rafts, 206 
whereas Ras was found predominantly in the Triton-soluble fraction and β-tubulin was exclusively 207 
in the cytosolic fraction (Fig. 4d).   208 
 Lipid rafts can be disrupted using the cholesterol depleting agent methyl-β-cyclodextrin 209 
(MβCD). We therefore next investigated whether or not raft disruption affected PKC and/or ERK 210 
signalling. Somules were treated with either high (10 mM) or low (1 mM)29,30 concentrations of 211 
MβCD for increasing durations prior to EGF exposure. ERK activation was visibly suppressed after 212 
20 min treatment with 1 mM MβCD, when compared with earlier time points (Fig. 5a). In contrast, 213 
ERK was activated at all time points using 10 mM MβCD, when compared with 1 mM MβCD 214 
treatment (Fig. 5a). In replicate experiments, there was no consistent pattern of PKC 215 
activation/inhibition in response to treatment with MβCD (Fig. 5a). Immunohistochemistry of 216 
somules treated with 1 mM or 10 mM MβCD for 20 min prior to EGF stimulation revealed that 10 217 
mM MβCD significantly increased ERK activation at the tegument of the parasite (Fig. 5b). These 218 
findings are consistent with lipid rafts playing a role in ERK pathway activation at the surface of 219 
somules.  220 
 221 
Modulation of PKC and ERK signalling in somules affects somule morphology and motility 222 
and reduces their survival.  We have previously validated GF109203X and PMA, and U0126, for 223 
use in S. mansoni as modulators of PKC and ERK activation, respectively13,15. In live parasites, 224 
GF109203X and U0126 attenuate S. mansoni PKC and ERK activation, respectively, and PMA 225 
activates PKC/ERK, but down-regulates PKC after prolonged (overnight) exposure13,15. Given that 226 
human EGF, insulin and IGF-I activated these pathways in somules, we aimed to understand the 227 
importance of these pathways to somule phenotype. Somules were therefore incubated in 228 
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increasing concentrations of GF109203X, PMA, or U0126, and movies taken after 2, 24 and 48 h 229 
and imported into ImageJ to assess the effect of treatments on somule length, area, standard 230 
deviation of perimeter (as a proxy for contractile motility), and morphology. In all cases, over 48 h, 231 
GF109203X, PMA, and U0126 did not significantly affect the mean overall length or area of 232 
somules (data not shown). However, at 2 h the PKC activator PMA (2 μM - 20 μM) significantly 233 
enhanced somule motility with a maximal ~4-fold increase at 10 μM (p≤0.01; Fig. 6b); no 234 
significant effect was seen at 2 h with the PKC inhibitor GF109203X or the MEK/ERK inhibitor 235 
U0126 (Figs. 6a, c). Control somules (including those in DMSO vehicle) also appeared to increase 236 
motility over time. In contrast, GF109203X (≥2 μM) markedly reduced somule motility after 24 and 237 
48 h, with almost no contractile movement detected at between 5 and 20 μM (p≤0.001; Fig 6a). On 238 
the other hand, U0126 only blunted motility when used at 50 μM (p≤0.001; Fig 6c).  239 
Further visual analysis of movies taken at 24 h revealed that these compounds affected 240 
somule morphology. When used at ≥30 μM all three compounds significantly increased the number 241 
of somules displaying a degree of granulation (p≤0.05), when compared to their respective 242 
controls, with GF109203X having the greatest effect at 50 μM (p≤0.001; Fig 7a). GF109203X (≥10 243 
μM), in turn caused somules to have darkened mid-region(s) (Fig. 7b), whereas PMA and U0126 244 
induced a more pronounced darkening of the whole somule body (Fig. 7c). Individual somules 245 
displaying a segmented body phenotype were also observed, particularly with the highest 246 
concentrations of each compound, where over 20% of somules displayed this morphology (Fig. 247 
7d). Finally, with 50 μM PMA the mean proportion of somules displaying swollen bodies (25%) was 248 
somewhat greater than DMSO vehicle controls (6%), however the difference did not reach 249 
statistical significance (data not shown). 250 
Somule viability was then determined at 48 h using a fluorescence-based assay31. 251 
Treatment of somules with 50 μM GF109203X resulted in reduced survival from 90% (control) to 252 
54% (p≤0.05) and the effect of U0126 on somule survival was broadly similar to that of 253 
GF109203X (Fig. 7e). On the other hand, PMA significantly reduced somule survival when 254 
employed at ≥10 μM; death rates of ~60% were observed with 50 μM PMA, when compared to 255 
DMSO treated controls (p≤0.01; Fig. 7e).  256 
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 257 
Discussion 258 
Focusing on early development of S. mansoni somules, we have determined the temporal and 259 
spatial activation patterns of PKC and ERK and have characterized their responses to human 260 
EGF, insulin, and IGF-I, in vitro. The findings highlight the dynamic nature of PKC and ERK 261 
signalling in this life stage and demonstrate that human growth factors/hormones have the capacity 262 
to modulate schistosome-signalling processes at least in vitro; if similar effects occur in vivo then it 263 
is plausible that such ‘transactivation’ by host molecules could possibly influence the outcome of 264 
host infection, schistosome survival and development. Analysis of lipid raft components such as 265 
flotillin, and of DRMs, supports the presence of lipid rafts in the parasite tegument, and treatment 266 
of somules with MβCD resulted in aberrant ERK activation at the tegument. We therefore 267 
hypothesise that lipid rafts in the parasite surface layer are likely to be important to host-parasite 268 
communication. Finally, incubation of somules with modulators of PKC and ERK activity revealed 269 
that these pathways seem to play a role in somule motility and survival. These protein kinases, that 270 
are regulated by host factors, therefore appear to be essential for S. mansoni somule homeostasis 271 
and might represent suitable drug targets in this and other species of human schistosome.  272 
 In vitro cultured somules displayed functionally activated PKC and ERK at their surface. 273 
Given that the tegument of adult worms displays activated PKC and ERK when fixed immediately 274 
after perfusion from mice15, we surmise that these kinases would also be activated at the somule 275 
surface in vivo. Interestingly, PKC/ERK activation also occurred at the somule tegument at 16 h 276 
when not exposed to serum. Somules might therefore possess endogenous mechanisms for 277 
tegumental PKC/ERK activation or respond to minimal components of BME, which include amino 278 
acids. Certain schistosome receptors can be triggered by non-growth factor like ligands, as has 279 
been shown in a Xenopus expression system with L-arginine, other amino acids, and the RTK-like 280 
Venus kinase receptors 1/2 (VKRs 1/2) that possess Venus flytrap (VFT) modules32,33. Importantly, 281 
when used at physiologically relevant concentrations, EGF, insulin and IGF-I activated the 81 kDa 282 
PKC and ERK, 116 kDa PKC and ERK, and 116 kDa PKC, respectively and at different times.  283 
Because PKC and ERK pathways govern a plethora of biological responses in organisms11,12,34, 284 
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this finding opens the possibility that host signalling molecules trigger somule development and co-285 
ordinate wide-ranging function in the parasite, with the different ligands influencing different 286 
outcomes through differential PKC and ERK signalling, perhaps in a manner that would differ 287 
between individual hosts. The EGF-mediated responses are likely delivered through SER, the S. 288 
mansoni EGF receptor (EGFR) homologue that was found to bind EGF in a Xenopus over-289 
expression system35, although four putative EGFR proteins have been mined bioinformatically16, 290 
with two (Smp_152680 and Smp_165470) currently curated in GeneDB. Stimulation of ERK 291 
signalling by EGF, which was particularly observed at the tegument, might be important during 292 
early host invasion during which the parasite will not only sense human EGF for the first time but 293 
must rapidly adapt to the host; thus, host-mediated ERK activation might drive tegument 294 
remodelling ensuring parasite survival in addition to promoting cell growth/differentiation. During 295 
host infection the somule will, however, be exposed to a complex mixture of host factors and cross 296 
talk between pathways will ensue. For example, the transforming growth factor β (TGFβ) pathway, 297 
a focus of much research in schistosomes36–39, is well known to crosstalk with the ERK pathway in 298 
a non-canonical fashion in humans40. Furthermore, in S. mansoni the linker region of common 299 
mediator (Co-)Smad4 contains three ERK phosphorylation motifs opening the possibility that ERK 300 
could restrict interaction of Smad4 with receptor activated (R-)Smad2 to modify TGFβ-mediated 301 
outcomes36,41. Activated protein kinase A (PKA) has also recently been shown to localise to 302 
multiple structures in S. mansoni somules including the tegument and PKA activation in somules 303 
was upregulated by human serotonin and dopamine but was supressed by neuropeptide Y42. 304 
Perhaps not surprisingly, PKA is known to influence ERK43 and PKC44 signalling in other systems 305 
through cross-talk to allow dynamic and specific control of signalling dependent upon input signal. 306 
It would be valuable to explore signal-mediated responses in somules that have penetrated 307 
through mouse skin or human skin equivalents to enable us to appreciate how a complex host 308 
environment might module multiple signalling events in schistosomes.  309 
With regard to insulin receptors, two types, SmIR-1 and SmIR-2, exist in S. mansoni and 310 
these can interact with human insulin45, with SmIR-1 preferentially localized to the somule 311 
tegument together with the glucose transporters STGP1 and SGTP4, and SmIR-2 localized to the 312 
parenchyma45. In adult worms, the receptor localization was broadly similar with muscular staining 313 
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also seen in the males45. Interestingly, however, despite the similar stimulatory effect of IGF-I on 314 
~116 kDa PKC activation in the current study, this ligand did not interact with either SmIR-1 or 315 
SmIR-2 in two-hybrid assays45. Thus the putative receptor(s) for the human IGF-I-mediated 316 
responses remain elusive even though S. mansoni also possess a putative IGF-I (Smp_151640; 317 
sourced at GeneDB). In a functional context, human insulin has been shown to increase 318 
schistosome glucose uptake whereas RNA interference (RNAi) of the IRs reduces uptake and 319 
impacts schistosome development46,47. Moreover, exposure of S. japonicum to human insulin 320 
modulated expression of 1,101 genes and, based on the findings of the current research, some of 321 
these effects would presumably have been driven through upregulated PKC and ERK signalling. 322 
Interestingly, a putative insulin-like peptide has recently been identified in S. mansoni48, although 323 
whether this peptide interacts with the SmIRs remains unknown.   324 
Prior to this research, isolation of DIGs from the tegumental double surface membrane of 325 
S. mansoni and identification of caveolae-like structures therein suggested that lipid rafts form in 326 
this host-interactive layer25, providing a hub for certain signalling events. Here, labelling of 24 h 327 
somules with CTB after exposure to EGF revealed that GM1 clusters exist at the schistosome 328 
surface, further supporting the presence of lipid rafts in S. mansoni. Such clusters were also 329 
visualized in the tegument of adult worms. Flotillins, evolutionarily conserved proteins that are 330 
anchored in cellular membranes including the plasma membrane, are thought to be important to 331 
raft organization and are used as DRM and thus lipid raft markers23,49–51. Using antibodies that 332 
target the highly conserved flotillin domain, a flotillin-like protein was found enriched in adult worm 333 
DRMs following sub-cellular fractionation and also localized to the tegument, sub-tegument and 334 
other regions of 24 h somules. Two other proteins, Ras and G protein (Gq) that are important to 335 
ERK and PKC signalling displayed similar in situ distribution to the flotillin-like protein, with Ras 336 
abundantly associated with the somule surface layer(s). Although we hypothesised that, similar to 337 
flotillin, Ras would be enriched in the triton-insoluble DRM fraction it was largely recovered in the 338 
triton-soluble fraction. However, not all Ras-related proteins associate with lipid rafts24,52 likely 339 
because of their prenylation/palmitoylation status whereby prenylation can exclude modified 340 
proteins from lipid rafts but palmitoylation enhances their raft interaction20,23,53. Furthermore, 341 
activation status can affect partitioning of certain Ras isoforms; for example, GTP-mediated 342 
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activation of H-Ras causes a conformational change that drives it out of lipid rafts54. Given that 343 
collectively our results further supported the existence of lipid rafts at the surface of schistosomes, 344 
we investigated the impact of raft disruption through cholesterol depletion using MβCD on PKC 345 
and ERK signalling. Although PKC activation was largely unaffected by MβCD, ERK activation was 346 
temporally suppressed by low (1 mM) MβCD concentrations but enhanced with a high (10 mM) 347 
dose, particularly at the tegument, supporting a role for cholesterol-rich lipid rafts in 348 
transmembrane signalling in schistosomes. It has been reported that EGF stimulation of ERK is 349 
enhanced in Rat-1 cells treated with MβCD55, but in contrast MβCD treatment alone has been 350 
shown to suppress ERK activation in human breast cancer cells56. Mechanisms/outcomes of 351 
growth factor signalling in rafts are complex and involve, amongst other factors, the architecture of 352 
the raft, the affinity of receptors for the raft and the downstream coupling of pathways21.  353 
Given that human EGF, insulin and IGF-I stimulated ERK and PKC activities in somules in 354 
vitro we wished to establish the importance of ERK and PKC activity to somule phenotype. We 355 
therefore employed a pharmacological approach57 using U0126, GF109203X, or PMA at seven 356 
wide-ranging concentrations to affect global PKC or ERK activation in somules. Somule movement 357 
was almost completely abolished by low doses (≥2 μM) of GF109203X and a high dose of U0126 358 
(50 μM) at 24 h with effects broadly more potent than those reported in adult S. mansoni over a 359 
similar duration15. Short-term (2 h) incubation with the PKC activator, PMA, stimulated movement 360 
whereas longer-term incubation (≥24 h) supressed movement in accord with the down-regulatory 361 
effect of this compound on PKC expression after 24 h15. Collectively, these findings support roles 362 
for PKC and ERK in somule muscular contraction and we hypothesise that PKC/ERK are 363 
fundamental to enabling the parasite to migrate within the skin to gain entry to the vasculature, 364 
possibly in response to host growth factors. Further visual analysis 24 h after drug treatment 365 
revealed that all three compounds (≥30 μM) increased the proportion of granulated somules, with 366 
GF109203X (≥10 μM) also enhancing numbers with dark mid-regions and PMA/U0126 (≥10 μM) 367 
inducing a more general dark-bodied phenotype; segmented somule bodies were also more 368 
prevalent with either compound, particularly when administered at 50 μM. The dose-responsive 369 
nature of the effects of these compounds on somule phenotype suggests that GF109203X, U0126, 370 
and PMA are acting specifically towards their intended targets in somules. Moreover, these 371 
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findings emphasise the value of classifying phenotype discretely in such experiments rather than 372 
labelling somules as simply ‘normal’ or ‘granulated’. Moreover, analysis of somule viability at 48 h 373 
using a fluorescence-based assay revealed that not all somules displaying heavily 374 
granulated/darkened bodies at 24 h were dead. However, PMA (≥10 μM), and at higher doses 375 
GF109203X and U0126 significantly increased somule mortality. Although we did not perform drug 376 
‘wash-out’ experiments to ascertain whether the phenotypic effects were reversible, granulation is 377 
often regarded as a phenotype that ultimately results in somule death. While in the present study 378 
we aimed to supress global PKC activation, RNAi of a single PKC (Smp_096310; atypical PKCι-379 
type) was recently shown to result in increased somule death after two weeks in the presence of 380 
human red blood cells58. In a separate study, RNAi of ERK1/2 was performed in S. mansoni 381 
somules, which were then injected into mice, and although ERK1/2 mRNA levels were supressed, 382 
reduced parasite survival in vivo was not seen when compared to controls59. Nevertheless, egg 383 
output by resultant adults decreased 44%, which was in accord with reduced ovary size59. In 384 
comparison, the increased somule death following ERK inhibition by U0126 observed after only 48 385 
h in the present study could be due to U0126 attenuating ERK pathway activation more potently 386 
that was achieved by RNAi (during which ERK1/2 transcripts were supressed by between 92 and 387 
33% on days 2, 4 and 7)59.  388 
In summary, this research provides the first insights into host-mediated modulation of ERK 389 
and PKC pathways in schistosomes in vitro and highlights the importance of these pathways to 390 
somule homeostasis. Moreover, further support is provided for the existence of lipid rafts at the 391 
schistosome surface and we hypothesise that such rafts mediate the transfer of multiple molecular 392 
signals from the host to the parasite that regulate parasite behaviour, growth and development.  393 
 394 
 395 
Methods 396 
 397 
Parasites. Biomphalaria glabrata snails infected with S. mansoni (Strain: NMRI) were provided 398 
by the NIAID Schistosomiasis Resource Center of the Biomedical Research Institute (Rockville, 399 
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MD, USA) through NIH-NIAID Contract HHSN272201000005l distributed through BEI Resources. 400 
When patent, snails were placed in filtered tap water (Brimak filter, Silverline) and were exposed to 401 
light to induce cercarial emergence; cercariae were then transformed mechanically to somules 402 
using an adaptation of published methods60–63. Collected cercariae in Falcon tubes were placed on 403 
ice for 15 min, centrifuged (100 g for 5 min) and the supernatant discarded; BME containing 404 
antibiotics/antimycotics (Sigma) was added to ~4 ml and tubes gently mixed and placed at 37°C to 405 
encourage cercarial movement. Cercariae were next vortexed for 5 min and Hanks Basal Salt 406 
Solution (HBSS) added to 7 ml after which tubes were placed on ice for 7 min and re-centrifuged 407 
for 2 min to separate the detached tails from heads; this process was then repeated. The 408 
supernatant was removed, BME added, and the suspension swirled in a high-walled glass Petri 409 
dish to concentrate somules into the centre. The somules were collected, enumerated, loaded into 410 
individual wells of 24-well culture plates (Nunc; ~1000 somules/1 ml of BME containing 411 
antibiotics/antimycotics), and incubated in 5% CO2 at 37°C. After 16 h somules were transferred 412 
into Basch’s medium64 and incubated in 5% CO2 at 37°C.  413 
 Adult worms were supplied by Bioglab Ltd, c/o Professor Mike Doenhoff, University of 414 
Nottingham, UK.  415 
 416 
Evaluating kinase activation during early somule development and in response to human 417 
factors.  The phosphorylation (activation) status of PKCs and ERKs was determined at 3, 16, 24, 418 
48, 72, and 96 h by western blotting. At each time point somules were transferred to cooled 419 
microfuge tubes, placed on ice for 1 min, and pulse centrifuged. Radio immunoprecipitation assay 420 
(RIPA) buffer (30 μl) (Cell Signalling Technology (CST), New England Biolabs)/HALT 421 
protease/phosphatase inhibitor cocktail (1 μl) (Pierce, Thermo Scientific) was added on ice to lyse 422 
the pelleted somules and, after brief (10 s) sonication, 2 μl aliquots were removed for protein 423 
quantification using Bradford reagent (Sigma) with bovine serum albumin (BSA) as the protein 424 
standard. An appropriate volume of SDS-PAGE sample buffer was added to the remaining lysate 425 
and samples heated for 5 min at 90°C and either electrophoresed immediately or stored at -20°C. 426 
SDS-PAGE performed with 10% Precise pre-cast gels (Pierce) and western blotting with anti-427 
phospho PKC (ζ Thr410), anti-phospho PKC (βII Ser660)), anti-phospho p44/42 MAPK (ERK1/2) 428 
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(Thr202/Tyr204) antibodies (CST; each at 1/1000) was carried out according to our previously 429 
published methods13,15,65–67. Anti-actin antibodies (Sigma; 1:3000) were used to assess protein-430 
loading differences. This was important because of difficulties experienced in obtaining equal 431 
numbers of parasites in each sample; phosphorylation levels were then normalised against 432 
differences in actin signal between samples15,65,68. 433 
 To determine whether PKC or ERK could be activated by host growth factors/hormones, 3-434 
day old somules that had been cultured in Basch’s medium and then starved by washing and 435 
culturing in serum-free BME overnight (~16 h) were treated with EGF (Merck; 15 ng/ml), IGF-I 436 
(Sigma, 15 ng/ml), insulin (Sigma; 1 μM), or were left untreated (BME, control). Exposure times 437 
and concentrations used were adapted from gene expression studies conducted in Schistosoma 438 
japonicum69, and also from work published with EGF in Trypanosoma brucei70. After exposure (5, 439 
15, 30, and 60 min for EGF/IGF-I; 30 and 60 min for insulin), somules were placed on ice and 440 
processed for western blotting as detailed above. In some experiments somules were also 441 
maintained in Basch’s medium (and were not washed/further treated) to evaluate the effect of this 442 
growth factor-rich medium on protein kinase activation.  443 
 In situ mapping of functionally activated PKCs and ERKs in somules with anti-phospho 444 
PKC (ζ Thr410), anti-phospho PKC (βII Ser660)), anti-phospho p44/42 MAPK (ERK1/2) 445 
(Thr202/Tyr204) antibodies (CST; each at 1/50 in 1% BSA in PBS), either during early 446 
development in vitro or in response to the various growth factor/hormone treatments, was 447 
performed according to our published methods15,65–67. For immunohistochemistry, actin was also 448 
stained with anti-actin cy3 conjugated antibodies. Somules were visualised using a Leica SP2 449 
AOBS laser scanning confocal microscope (40x or 63x objectives) and images captured; 450 
photomultiplier tube voltages and laser settings were equal for each comparative experiment. 451 
Because kinase activation within individual somules of a population might vary slightly, only 452 
somules that displayed activation patterns common to the vast majority of those present were 453 
selected for image capture.  454 
 455 
Identification of lipid rafts/raft markers. Lipid raft staining in somules and adult worms was done 456 
using the AlexaFluor 594 lipid raft labelling kit (Invitrogen). Somules, cultured for 24 h in serum-457 
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free BME, were exposed to EGF (15 ng/ml) for 5 min or left untreated and were then placed on ice. 458 
Adult worms were also exposed to EGF (15 ng/ml). Parasites were then immediately washed in 2 459 
ml chilled BME and incubated with fluorescent cholera toxin B subunit (CT-B) conjugate (1 μg/ml) 460 
for 10 min. Next, parasites were washed thrice with 2 ml PBS before incubating in anti-CT-B 461 
antibody solution for 15 min to crosslink the CT-B conjugate. After further PBS washes parasites 462 
were pelleted (somules) at 200 g in a centrifuge, or (adults) carefully removed, and fixed in ice-cold 463 
acetone for 30 min. All of the above incubations and washes were performed on ice. Parasites 464 
were then transferred to slides, mounted in Vectashield mounting medium (VectorLabs) and 465 
visualized on a Leica SP2 AOBS laser scanning confocal microscope. 466 
 To identify commercially available antibodies that might react with S. mansoni flotillin, Gq 467 
and Ras, protein sequences for Homo sapiens flotillin-1 (NP_005794.1), Gq/α11 (NP_002058), 468 
and K-Ras (NP_203524) were initially retrieved from the National Center for Biotechnology 469 
Information (NCBI: http://www.ncbi.nlm.nih.gov/protein), a BLAST (Basic Local Alignment Search 470 
Tool) search performed against S. mansoni protein sequences held within GeneDB 471 
(www.GeneDB.org), and pair-wise protein alignments constructed using Uniprot Align 472 
(http://www.uniprot.org/align/). Antibodies were then selected according to homology within the 473 
antibody binding regions. Identified antibodies (anti-flotillin 1 (1/500), 610820, BD Biosciences; 474 
anti-Gq/α11 (1/1000), CT|06-709, Millipore; anti-Ras (1/1000), 3965 – CST) were next screened 475 
for immunoreactivity against S. mansoni somule protein extracts by western blotting as detailed 476 
above. Adult worm protein extracts were prepared by homogenizing one worm pair in 30 μl RIPA 477 
buffer and processing further as detailed for somules and rat brain lysates were used as a 478 
mammalian control. Somules were next processed for immunohistochemistry (as detailed above) 479 
with anti-flotillin 1, anti-Gq/α11 and anti-Ras antibodies (each at 1/50) to determine the in-situ 480 
expression patterns of the respective proteins.    481 
 482 
Preparation of DRMs and disruption of lipid rafts. Preparation of DRMs was achieved 483 
according to Adam et al28. Adult worms (50 pairs) were homogenized on ice in 150 μl buffer ‘A’ (25 484 
mM 2-(N-morpholino)-ethanesulfonic acid (MES), 150 mM NaCl, pH 6.5, incorporating HALT 485 
protease/phosphatase inhibitors) using a motorised microfuge pestle and the detergent-free 486 
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extracts centrifuged at 500 g for 5 min at 4°C to pellet cellular debris, nuclei and intact cells. The 487 
supernatant was then centrifuged at 16,000 g for 10 min, 4°C, and the resultant supernatant 488 
retained at the cytosolic fraction. The high–speed pellet was next subject to successive detergent 489 
extraction by initially resuspending in buffer ‘A’ and combining with an equal volume of buffer ‘A’ 490 
containing 2% triton X-100. Samples were then incubated on ice for 30 min, centrifuged at 16,000 491 
g for 20 min at 4°C and supernatants collected as the triton-soluble (TS) fraction. Pellets were 492 
rinsed in buffer ‘A’ and resuspended in buffer ‘B’ (10 mM Tris-Cl, 150 mM NaCl, 60 mM β-493 
octylglucoside, with protease/phosphatase inhibitors), incubated on ice for 30 min, centrifuged at 494 
16,000 g for 20 min at 4°C and supernatants collected as the triton-insoluble (TI) fraction. A 10 μl 495 
aliquot of each fraction was removed for protein estimation (using the Bio-Rad detergent-496 
compatible protein assay) and an appropriate amount of 5x SDS-PAGE loading buffer added; 497 
samples were then heated and processed for Western blotting with anti-flotillin, anti-Ras, and anti-498 
β-tubulin antibodies (1/1000) as detailed earlier.  499 
 To assess the effects of raft disruption by cholesterol depletion on signalling, 24 h in vitro 500 
cultured somules were incubated with MβCD (1mM or 10 mM) for 5, 10, 20 or 30 min prior to 501 
stimulation with EGF (15 ng/ml) for 5 min. Samples were then processed for Western blotting with 502 
anti-phospho-PKC (ζ Thr410) and anti-phospho p44/42 MAPK (ERK1/2) (Thr202/Tyr204) 503 
antibodies as detailed above. Somules obtained at 20 min MβCD/5 min EGF exposure were also 504 
processed for immunohistochemistry with anti-phospho p44/42MAPK (Thr202/Tyr204) (ERK1/2) 505 
antibodies (above). A single z-scan through the centre of each somule was captured using a Leica 506 
SP2 AOBS laser scanning confocal microscope and the fluorescence intensity across the parasite 507 
in two randomly selected places was determined using Leica quantification software.  508 
 509 
Functional and viability assays. Newly transformed somules (~300 per well) were maintained 510 
overnight (16 h) in individual wells of a 48-well tissue culture plate in 300 μl serum-free BME 511 
containing various concentrations (1-50 μM) of GF109203X, U0126, or PMA, or in BME alone/BME 512 
plus DMSO (at 0.1% or 1 %; vehicle controls for U0126 and PMA). The next day, BME was 513 
replaced with Basch medium and pharmacological agents/DMSO added in the same manner. 514 
Movies (each 1 min long, 13 frames/s) of somules were recorded with a digital Motic camera 515 
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attached to a Motic inverted microscope 2, 24 and 48 h after adding the Basch medium (containing 516 
components), and the behavioural/morphological effects observed and quantified. Movies were 517 
converted to uncompressed AVI using VirtualDub (www.VirtualDub.com) and imported into ImageJ 518 
for Windows (www.rsbweb.nih.gov/ij/) running the wrMTrck plugin 519 
(www.phage.dk/plugins/download/wrMTrck.pdf). Frames were converted to greyscale, background 520 
subtraction and Otsu thresholding applied and somules analyzed with wrMTrck. Three parameters 521 
were evaluated: average total somule area, average total somule length, and standard deviation of 522 
the perimeter in all observed frames, that latter of which was used as a proxy for determining 523 
somule movement (contractions and distensions). When somules were touching each other, 524 
results of those individuals were discarded as the software considers them as one object. In 525 
addition, a visual analysis of somule phenotype was performed at 24 h with somules categorized 526 
as normal, granulated, possessing a darkened mid-region or entire body, or being segmented or 527 
swollen. 528 
 At 48 h, 100 parasites per treatment were removed and their survival determined using a 529 
fluorescein diacetate /propidium iodide (FDA/PI) viability assay31. Briefly, somules were transferred 530 
to microfuge tubes, centrifuged (200 g for 10 s) and each pellet washed twice in warmed (37°C) 531 
PBS before adding 200 μl PBS containing 2 μg/ml PI and 0.5 μg/ml FDA. Immediately after, 532 
parasites were transferred to black-walled microtitre plates and fluorescence measured in dual 533 
mode with 544 nm excitation/620 nm emission (to detect PI/dead) and 485 nm excitation/520 nm 534 
emission (to detect FDA/live) with a FluorStar Optima plate reader. All fluorescence values were 535 
obtained at 10 min with the plate reader incubator set at 37°C to keep temperature constant to 536 
ensure sufficient esterase conversion of fluorescein diacetate to fluorescein within the live 537 
parasites. Two controls were employed, a positive control comprising untreated somules (live) and 538 
a negative control of heat-killed somules (65°C for 10 min); a blank of PBS/FDA/PI was also used 539 
to compensate for any inter-plate variation. In order to ascertain percentage of live and dead 540 
somules in each treatment group the following formula was used: viability = live (FDA 541 
fluorescence)/(dead (PI fluorescence) * live (FDA fluorescence) x 100, where live (FDA 542 
fluorescence) = (sample – negative control) / (pos. control – negative control) and dead (PI 543 
fluorescence) = (sample – blank) / (negative control – blank)31.  544 
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 545 
Statistical analysis. Statistical comparisons were performed with one-way analysis of variance 546 
(ANOVA) using Minitab (version 16). All data were expressed as mean ±SEM, and statistical 547 
significance was determined by Fisher’s multiple pair-wise comparison.  548 
 549 
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Figure Legends 569 
 570 
Figure 1 | PKC and ERK activation during S. mansoni early somule development in vitro. (a) 571 
Detection of phosphorylated (activated) PKCs (p-PKC) and ERKs (p-ERK) in somules during 96 h 572 
culture by western blotting using anti-phospho PKC (Ser660)/(Thr410) or anti-phospho 573 
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p44/42MAPK (Thr202/Tyr204) (ERK1/2) antibodies. Anti-actin antibodies were used to monitor 574 
differences in total protein loading between lanes. (b) In situ localization of activated kinases 575 
(green) within somules at 3, 16 and 96 h using anti-phospho PKC (Ser660)/(Thr410) or anti-576 
phospho p44/42MAPK (Thr202/Tyr204) (ERK1/2) primary and AlexaFluor 488 secondary 577 
antibodies and confocal microscopy. F-actin is stained with rhodamine phalloidin (red). 578 
Representative micrographs of somules are shown as z-axis maximum projections. Bar = 25 μm. 579 
 580 
Figure 2 | Human EGF stimulates PKC and ERK activation in S. mansoni somules. (a) 72 h in 581 
vitro-cultured somules, starved overnight, were exposed to EGF (15 ng/ml; 5 – 60 min) and 582 
phosphorylated (activated) PKCs (p-PKC) and ERKs (p-ERK) detected by western blotting with 583 
anti-phospho PKC (Ser660) or (Thr410) and anti-phospho p44/42MAPK (Thr202/Tyr204) (ERK1/2) 584 
antibodies. Control somules (in BME) remained untreated, and somules cultured in complete 585 
Basch media were also processed. Band intensities on blots were quantified and mean relative 586 
change in phosphorylation (n = 5, ±SEM; graph), normalised for actin levels, was calculated with 587 
respect to BME controls that were assigned a value of 1; **p≤ 0.01, ***p≤ 0.001. (b) In situ 588 
localization of activated PKC and ERK (green) within 72 h somules with or without EGF treatment 589 
using anti-phospho PKC (Thr410), anti-phospho p44/42MAPK (Thr202/Tyr204) (ERK1/2) and 590 
AlexaFluor 488 antibodies and confocal microscopy. Representative micrographs of somules are 591 
shown as z-axis maximum projections, except for the right-hand side images, which are single z-592 
sections through the parasite. Bar = 25 μm. 593 
 594 
Figure 3 | Human insulin and IGF-I stimulate PKC and ERK activation in S. mansoni 595 
somules. (a) 72 h in vitro-cultured somules, starved overnight, were exposed to insulin (1 μM; 30, 596 
60 min) and phosphorylated (activated) PKCs (p-PKC) and ERKs (p-ERK) detected by western 597 
blotting with anti-phospho PKC (Ser660) or (Thr410) and anti-phospho p44/42MAPK 598 
(Thr202/Tyr204) (ERK1/2) antibodies. Control somules (in BME) remained untreated. Band 599 
intensities were quantified and mean relative change in phosphorylation (n = 6, ±SEM; graph), 600 
normalised for actin levels, was calculated with respect to BME controls that were assigned a 601 
value of 1; **p≤ 0.01, ***p≤ 0.001. (b) In situ localization of activated PKC and ERK (green) within 602 
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72 h somules following insulin treatment using anti-phospho PKC (Ser660), anti-phospho 603 
p44/42MAPK (Thr202/Tyr204) (ERK1/2) and AlexaFluor 488 antibodies and confocal microscopy. 604 
(c) Detection of activated PKC in response to IGF-I exposure with time using anti-phospho PKC 605 
(Ser660) antibodies. Representative micrographs of somules are shown as z-axis maximum 606 
projections. Bar = 25 μm. 607 
 608 
Figure 4 | Identification of lipid rafts in S. mansoni (a) In situ detection of lipid rafts in control (-609 
EGF) 24 h somules or 24 h somules/adult male worms treated with EGF (15 ng/ml; +EGF) for 5 610 
min, stained live with the AlexaFluor 594 lipid raft labelling kit and imaged by confocal microscopy. 611 
(b) Identification of flotillin, Gq and Ras in adult worms (1 pair) and 24 h somules (~1000) by 612 
western blotting (with rat brain positive control) and in situ localization within somules by confocal 613 
microscopy using anti-flotillin, anti-Gq, and anti-Ras antibodies. The inset panels display 614 
localization of these proteins at the tegument region. (c) Detailed in situ analysis of PKC and ERK 615 
activation in 24 h somules exposed to EGF (15 ng/ml) using anti-phospho PKC (Thr410) and anti-616 
phospho p44/42MAPK (Thr202/Tyr204) (ERK1/2) antibodies. (d) Separation of triton-insoluble 617 
(detergent-resistant) membranes from triton-soluble membranes and cytosolic fraction and 618 
identification of flotillin, Ras and tubulin within each fraction by Western blotting; each lane 619 
contains equal amounts of total protein (39 μg) derived from fractionation of adult worm extracts. 620 
Representative micrographs of somules are single z scans. Bar = 25 μm. 621 
 622 
Figure 5 | Lipid raft disruption through cholesterol depletion affects ERK signalling in S. 623 
mansoni somules. Somules (~1000) were incubated in 1 or 10 mM methyl-β-cyclodextrin (MβCD) 624 
for 5–30 min and subsequently exposed to 15 ng/ml EGF. Somule protein extracts were processed 625 
for western blotting with anti-phospho PKC (Thr410) or p44/42MAPK (Thr202/Tyr204) (ERK1/2) 626 
antibodies; anti-actin antibodies were used to monitor total protein loading differences between 627 
lanes. Results are representative of those seen in two independent experiments. (b) In situ 628 
analysis of ERK activation in somules exposed to 1 or 10 mM MβCD for 20 min followed by 15 629 
ng/ml EGF, using anti-phospho p44/42MAPK (Thr202/Tyr204) (ERK1/2) antibodies. The 630 
fluorescence intensity at the tegument (e.g. at locations ♯1 and ♯2 of a single confocal z scan) was 631 
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quantified (line graph) at two separate random locations for each somule (n=15) and mean 632 
fluorescence intensity calculated (±SEM; bar chart). Bar = 25 μm.   633 
 634 
Figure 6 | Modulation of PKC or ERK signalling affects the motility of S. mansoni somules. 635 
Somules were incubated in increasing concentrations of (a) GF109203X, (b) PMA, or (c) U0126 636 
and movies captured at 2 h, 24 h, or 48 h. Motility (standard deviation of perimeter) of somules 637 
was determined using ImageJ over 10 s at each time point, with mean values (±SEM; n=30) 638 
determined from three independent experiments. *p≤0.05, **p≤ 0.01, and ***p≤ 0.001, when 639 
compared to respective control values as follows: GF109203X = media (control); PMA and U0126: 640 
1 – 30 μM = 0.1% DMSO, 50 μM = 1% DMSO. 641 
 642 
Figure 7 | Modulation of PKC or ERK signalling affects morphology and survival of S. 643 
mansoni somules. (a-d) Somules were exposed to increasing concentrations of GF109203X, 644 
PMA, or U0126, movies captured at 24 h, and aberrant phenotypes (granulated, dark mid-region, 645 
dark body, and segmented body, respectively; shown in insets) enumerated as a percentage of the 646 
population observed across three independent experiments (mean ±SEM, n=30). (e) Mean viability 647 
(±SEM) of somules in response to GF109203X, PMA, or U0126 treatment after 48 h culture. 648 
*p≤0.05, **p≤ 0.01, and ***p≤ 0.001, when compared to respective control values as follows: 649 
GF109203X = media (control); PMA and U0126 DMSO: 1 – 30 μM = DMSO 0.1%, 50 μM = DMSO 650 
1%. 651 
 652 
 653 
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